opioid use disorder

News

Pear extends digital therapeutics partnership with Spero

Addiction treatment specialist Spero Health has expanded an agreement to use Pear Therapeutics’ prescription digital therapeutics (DTx) in its network of US clinics.

News

Indivior boosts addiction drug business with $145m Opiant de...

UK-based pharma Indivior has agreed a takeover deal with Opiant Pharma that consolidates its position in the addiction treatment category with a new intranasal therapy, due to be filed with

News

Telehealth cuts overdoses for opioid users, says study

Greater use of telehealth services forced by COVID-19 seems to have benefitted people with opioid use disorder (OUD), leading to longer times on treatment and reduced risk of overdose, acco

News

Digital therapeutic cuts opioid use disorder care costs, say...

A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it had 46% fewer hospital stays than a control group, saving more than $2,700 over a

News

NIH starts trial of Pear, Chess apps for opioid use disorder

Patient recruitment has begun in a National Institutes of Health (NIH) trial of two digital therapeutics (DTx) for people with opioid use disorder (OUD), developed by Pear Therapeutics and

News